- Home
- FTHM vs AYTU Comparison
FTHM vs AYTU Comparison
Compare FTHM & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHM | AYTU |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 25.7M |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FTHM | AYTU |
|---|---|---|
| Price | $0.82 | $2.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $2.50 | ★ $9.33 |
| AVG Volume (30 Days) | ★ 145.0K | 43.3K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.71 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $420,477,000.00 | $27,632,080.00 |
| Revenue This Year | $18.88 | N/A |
| Revenue Next Year | N/A | $43.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 25.45 | ★ 277.47 |
| 52 Week Low | $0.48 | $0.98 |
| 52 Week High | $3.37 | $3.07 |
Technical Indicators
Market Signals| Indicator | FTHM | AYTU |
|---|---|---|
| Relative Strength Index (RSI) | 53.10 | 47.22 |
| Support Level | $0.70 | $2.46 |
| Resistance Level | $0.85 | $2.66 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 80.95 | 20.00 |
Price Performance
Historical ComparisonAbout FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.